4
Oct 30 (Reuters) – Boehringer Ingelheim: * BOEHRINGER INGELHEIM REGISTERS PHASE III TRIAL INVESTIGATING VERDUCATIB IN COPD Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
